Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxalen-2-yl)propyl)piperazine
1. 84625-59-2
2. Dotarizine [inn]
3. Dotarizinum
4. Dotarizina
5. 1-benzhydryl-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazine
6. Io7663s6d3
7. 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)piperazine
8. Dotarizinum [latin]
9. Dotarizina [spanish]
10. 1-benzhydryl-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)piperazine
11. 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazine
12. Unii-io7663s6d3
13. Fi-6026
14. Dotarizine [mi]
15. Irganox259
16. Mls006010920
17. Schembl333044
18. Chembl2106316
19. Dtxsid60233630
20. Chebi:138033
21. Zinc22058279
22. Piperazine, 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)-
23. Db06446
24. Smr002530536
25. Db-056814
26. Ft-0630930
27. Q5299417
28. 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)]piperazine
29. 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]-piperazine
30. 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazin
| Molecular Weight | 442.6 g/mol |
|---|---|
| Molecular Formula | C29H34N2O2 |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 442.262028332 g/mol |
| Monoisotopic Mass | 442.262028332 g/mol |
| Topological Polar Surface Area | 24.9 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 534 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in migraine and cluster headaches.
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ABOUT THIS PAGE
A Dotarizine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dotarizine, including repackagers and relabelers. The FDA regulates Dotarizine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dotarizine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dotarizine supplier is an individual or a company that provides Dotarizine active pharmaceutical ingredient (API) or Dotarizine finished formulations upon request. The Dotarizine suppliers may include Dotarizine API manufacturers, exporters, distributors and traders.
Dotarizine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dotarizine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dotarizine GMP manufacturer or Dotarizine GMP API supplier for your needs.
A Dotarizine CoA (Certificate of Analysis) is a formal document that attests to Dotarizine's compliance with Dotarizine specifications and serves as a tool for batch-level quality control.
Dotarizine CoA mostly includes findings from lab analyses of a specific batch. For each Dotarizine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dotarizine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dotarizine EP), Dotarizine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dotarizine USP).
LOOKING FOR A SUPPLIER?
